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Many virus infections are associated with an inflammatory response characterized 
by more or less homogenous accumulations of inflammatory cells. For example, in 
poliomyelitis focal collections of  neutrophils are found  in  association with  infected 
and  damaged  anterior horn  motor  neurons.  On  the  other  hand,  many  meningo- 
encephalitis-inducing viruses give rise to  infections characterized by predominantly 
lymphocytic and monocytic infiltrations. There  is very little information regarding 
the factors that promote the accumulation of one or the  other of the  various inflam- 
matory cell types at sites of virus infection. 
One approach which has proved useful in the study of various kinds of inflammatory 
responses has been the investigation of various factors which cause specific, unidirec- 
tional migration (chemotaxis) of inflammatory cells. Most of the studies along these 
lines have made use of the Boyden technique, which allows for quantitative measure- 
ments of chemotaxis in vitro (1, 2). By this technique, many leukotactic factors have 
been discovered. Factors have been found which  are  active  for  neutrophils  (3-5), 
eosinophils (6, 7), macrophages (8, 9), and lymphocytes (3). Some of the chemotactic 
factors are active for more than one type of inflammatory cell, while others appear to 
be cell specific. Some of the factors described are derived from substances endogenous 
to the experimental animal under study; for the most part these are products of com- 
plement activation or substances released by antigen-activated, sensitized immuno- 
competent cells. The complement-derived factors are usually released as a consequence 
of  activation of  the  complement system,  resulting in  alteration and/or  cleavage of 
complement components by enzymes intrinsic to the complement system. Recently, it 
has been shown that certain mammalian cells contain substances that can cleave the 
third  or  the  fifth  components  of  complement productive  of  chemotactic  peptides 
(10-12). These substances may represent enzymes. Many other enzymes extrinsic to 
the complement system can likewise generate similar or identical chemotactic factors 
(13,  14). 
Leukotactic factors may also be derived from endogenous materials, for  example, 
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the  substance  obtained  from  filtrates  of  Escherichia  coli  cultures.  This  material  is 
chemotactic  for  neutrophils  and,  to  a  lesser  extent,  for  eosinophils  (7,  13).  Virus 
particles themselves have not been shown to possess such activity. However, infection 
of  tissue  cultures  with  herpes  simplex virus  results  in the release of a  factor which 
generates  from  C5  a  leukotactic  product  (12).  Similar leukotactic  factor~enerating 
activity may be obtained from lysates of uninfected cultures (12). Thus, this generator 
of leukotactic activity exists in normal cells and may represent a  lysosomal enzyme. 
The data  to be presented in this paper will show that when chicken embryos 
or  monkey kidney-derived  tissue  cultures  are  infected with  mumps  (MV) ~ or 
Newcastle  disease  virus  (NDV),  chemotactic  activity  for  neutrophils  and 
macrophages  can  be  detected  in  the  various  supernatant  fluids.  The  leuko- 
tactic material  described here is not obtainable  from uninfected  materials  and 
does not discernibly depend upon complement components for activity. 
Materials  and Methods 
Virus Preparation.--A  preparation of  the Victoria  strain of NDV  (109.3 ELD50/ml was 
used. 9-day chick embryos were inoculated with 106"a ELD 5o of NDV and incubated at 35°C; 
the allantoic fluid was harvested 48 hr later. MV strains used were the chick embryo-adapted 
Enders  strain  (10 s'6 EIDs0/ml)  and  the mammalian cell-adapted  ABC  strain  (1.2 X  107 
plaque-forming units/ml). 8-day chick embryos were inoculated with 10  ~' 6 EIDs0 of Enders 
strain virus and incubated at 35°C; the altantoic fluid was harvested 120 hr later. ABC virus 
was inoculated into monolayer cultures of BGM cells, a continuous line of African green mon- 
key kidney cells (15). Cultures were maintained with Medium 199 containing 2O-/o fetal calf 
serum penicillin (100 units/ml), and streptomycin (100 #g/ml). Culture fluids were harvested 
after 48 hr incubation at 37°C. 
Leukotactic  Assays.--A  modified Boyden chamber  technique was  used. This procedure, 
which has been described in detail (16), involves the separation of a chamber into an upper 
compartment containing leukocytes, and a lower compartment containing the putative leuko- 
tactic substance. The two compartments are separated by a micropore filter. Migration of cells 
through the pores of the filter in excess of that observed in control chambers, which either lack 
leukotactic substance  or contain the same concentration of the substance in both chambers 
(to abolish the gradient), is taken as evidence of leukotactic activity. In the present experi- 
ments, indicator cells consisted of rabbit neutrophils obtained by the intraperitoneal injection 
of 0.1% glycogen in saline 4 hr previously (10) or rabbit macrophages obtained 4 days after 
the intraperitoneal injection of mineral oil (8). All cells were suspended in Medium 199 with 
10% homologous serum. In several experiments it was shown that suspension of cells in 0.1% 
bovine serum albumin gave similar results, indicating that serum was not required in the cell 
suspension for the detection of chemotactic activity. Unless otherwise indicated, 10~)/zl of the 
various substances  tested for chemotactic activity was added  to appropriate compartments. 
Cell migration was quanfitated by counting the number of migrating cells in five high-power 
fields under a light microscope.  When neutrophils were used, filters of pore size 0.65/z were 
used in the chambers; with macrophages 5/z pore filters were utilized. 
Centrifugation  Studies.--Ultracentrifugation  was performed in a Beckman L2-65 ultracen- 
trifuge (Beckman Instruments Inc., Fullerton, Calif.) using a swinging bucket rotor at 45,000 
rpm (200,000 g) for 15 hr at 4°C. Sucrose gradients from 7.5 to 35% were made up in phosphate 
buffer, pH 7.3, ionic strength 0.05.  Details of this procedure have been previously described 
(16). 
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Complement Ccmponents.--The third (C3) and the fifth (C5) components of human comple- 
ment were isolated according to the method of Nilsson and Mfiller-Eberhard (17). These indi- 
vidual complement  components  were mixed with the various culture fluids and appropriate 
volumes of phosphate-buffered  saline (pH 7.4) in a total volume of 0.25 ml and incubated for 
the indicated period of time at 37°C, and the mixtures were then diluted to 1.0 ml with Medium 
199. These fluids were subsequently tested for leukotactlc activity. By this procedure it is pos- 
sible to determine if a culture fluid contains a material, such as an enzyme, that will generate 
leukotactic activity from added complement components  (18). 
RESULTS 
Newcastle  Disease  Virus  [nfection.--Allantoic  fluids  from  NDV-infected 
chicken embryos were assayed for leukotactic activity. As indicated in Table 
I,  such  fluids contained  leukotactic  activity for  neutrophils  in  each  of  four 
different experiments,  while the control fluids from  embryos inoculated with 
T~LEI 
Neuhoph~emotact~ActMtymNDV~nf~tedAllantoicNu~ 
Material tested 
Leukotaetie activity* 
Exp. A  B  C  D 
100 #I 
Uninfected allantoic fluid  10  40  0  15 
Infected al]antoic fluid  115  145  50  190 
Infected allantoic fluid, 
ultracentrifuged: 
Supernate  --  --  45  155 
Pellet  --  --  20  50 
Medium 199  0  0  0  0 
* Sample volumes of 100/zl tested. 
virus-free diluent  (phosphate-buffered saline)  showed  little or no  activity. In 
order to define the nature of the leukotactic activity, two fluids (Table I, exps. 
C  and D) were submitted to centrifugal forces of 200,000 g for 4 hr. The super- 
nates and pellets were then obtained, the  latter being resuspended in Medium 
199 to the starting volume. Leukotactic activity was assessed in each prepara- 
tion and found to be present predominantly in the supernate fractions (Table 
I, exps.  C  and D).  The lower,  but definite, level of activity in the pellets was 
probably due to a  carry-over of supernatant fluid with the pellet in the centri- 
fuge tube, since pellets were not washed before resuspension. These results sug- 
gest that the leukotactic activity in the infected fluids is associated not with in- 
tact virus particles but, rather, with a nonsedimenting material. 
Dose responses for fluids from NDV-infected embryos were determined (Fig. 
1).  Fluids A  and  B,  from  two  different experiments,  showed  similar dose-re- 
sponse relationships with a direct correlation between volume of the fluid tested 
and the amount of the leukotactic activity. One fluid (B) was also centrifuged 
(as  above),  and  the  supernate  was  compared with  the  original infected fluid 1098  VIRAL  LEUKOTACTIC  FACTORS 
(Fig. 1). That both lines are nearly congruent suggests that removal of the virus 
by ultracentrifugation does not alter the concentration of leukotactic activity 
in the fluid. This supports the contention that leukotactic activity is not asso- 
ciated with virus particles per se. 
Macrophage Chemotaetic Activity.--We  next attempted to explore chemotactic 
activity for mononuclear cells as well  as  neutrophils.  The indicator  cells for 
these  experiments  were  macrophages  from peritoneal  exudates,  obtained  as 
described above. Chicken embryos were infected with  either NDV or Enders 
strain MV. The results are shown in Table II. Significant levels of macrophage 
chemotactic activity were present in both preparations. These fluids were also 
assayed for neutrophil activity and found to be positive, with results quantita- 
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Fio. 1. Dose responses of allantoic fluids from NDV-infected chick embryos•  In both exper- 
iments A and B, the dose response curves are linear. "B Supernate" is fluid B ultracentrifuged 
to remove viral particles. 
tively similar to  those of the previous experiment (Table I). In comparison, 
the MV-infected material was over twice as effective for macrophage, as com- 
pared  with  the  NDV-infected  material.  It  is  not  known  if  the  leukotactic 
activity  in  these  preparations  consists  of  two  factors,  each  uniquely  active 
for one type of leukocyte (3),  or if there is one factor with  activity for both 
types  of  leukocytes  (8).  Supernates  from freeze-thawed uninfected  chorioal- 
lantoic membranes were devoid of either type of activity, as was allantoic fluid 
from intact embryos inoculated with diluent alone. 
Tissue Culture Studies.--Fluids  from ABC MV-infected BGM  cell cultures 
were assayed for leukotactic activity. These results are seen in Table III. Again, 
chemotactic  activity  for  both  neutrophils  and  macrophages  was  detected. 
Supernates  of freeze-thawed cultures  were negative for chemotactic activity, 
suggesting that nonspecific cell injury does not lead to the release of preformed 
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Density Gradient Analysis of the  Virus-Stimulated Leukotactic Factors.--The 
chemotactic activity in fluids from chicken embryos infected with NDV or MV 
and  in fluid from MV-infected cell  cultures was studied  by density gradient 
centrifugation.  Chemotactic  activity  for  neutrophils  in  the  NDV-infected 
allantoic fluid was biphasic; one peak sedimented near the IgG marker and the 
second sedimented near the cytochrome c marker (Fig. 2, upper frame).  Two 
similar zones of activity were noted in allantoic fluid from chick embryos in- 
fected with MV (Fig. 2, lower frame). On the other hand, fluid from a cell culture 
TABLE II 
Macrophage and Neutrophil Chemotactic Activity in NDV- or MV-Infeeted Allantoie Fluids 
Materia Ytested 
Chemotaetic activity 
Macrophage  Neutrophil 
150 Izl 
Allantoic fluid, diluent inoculated 
Allantoic fluid, NDV infected 
Allantoic fluid, MV infected 
Supernate, freeze-thawed chorioallantoic 
membrane 
0  0 
95  120 
260  145 
0  0 
TABLE III 
Macrophage and Neutrophil Chematactic Activity in MV-Infected Cell Culture Fluhts* 
Material tested 
Chemotactic activity 
Macrophages  Neutrophils 
150 ml 
Culture fluid, uninfected  0  20 
Culture fluid, MV infected  170  150 
Supernate, freeze-thawed culture cells  0  0 
Medium 199  0  0 
* BGM cells maintained in Medium 199 as defined in text. 
infected with MV showed activity that was limited to a zone coincident with 
the IgG marker (Fig. 2, middle frame). These studies indicate a similarity in dis- 
tribution of chemotactic factors in allantoic fluids infected with two different 
viruses.  Conversely,  the  same  virus  (MV)  grown  in  two  different  systems 
(embryo vs. cell culture)  led to a different ultracentrifugal distribution of leu- 
kotactic activity in the culture fluids. 
Complement-Derived  Leukotactic  Activity.--Brier  et  al.  (12)  have  reported 
that tissue  culture fluid from rabbit kidney monolayers infected with herpes 
simplex  virus  will  release  a  material  capable  of  generating  a  C5-dependent 
factor chemotactic for neutrophils. We tried to determine if the fluids used in 
the present studies had similar complement-dependent leukotactic factor-gen- 1100  VIRAL  LEUKOTACTIC  FACTORS 
erating  activity in  addition  to the  chemotactic activity described  above. In 
these experiments, 5 #1 volumes of various fluids (an amount containing no de- 
tectable leukotactic activity) were added to purified preparations of human C3 
or C5  (20/zg each). The mixture was incubated at 37°C for 10 rain and  then 
assayed for chemotactic activity. The results  are  shown in Table IV.  Fluids 
IoG  BSA  Cytochrome 
NEWCASTL  
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FIo. 2. Ultracentrifugation analysis in sucrose density gradients of chemotactic activity in 
fluids from virus-infected supernates (allantoic fluid, upper  and lower frames)  and BGM cell 
culture fluid (middle frame). This direction of sedimentation is from right to left. Protein stand- 
ards are indicated: IgC (human), bovine serum albumin (B SA), and cytochrome c. 
TABLE  IV 
Generation of Neutrophil  Chemotactlc Activity by Addition  of Human C3 or C5 to Culture Fluids 
qf Mumps  and  Nezc,castle Disease  Viruses 
Material incubated with complement* 
Allantoic fluid, uninfected 
Allantoic fluid, NDV infected 
Allantoic fluid, MV infected 
MV-infected ceil culture fluid 
Cell culture fluid, uninfected 
Leukotactic activity generated from 
C3  C5 
0  0 
35  110 
85  110 
0  20 
0  25 
* Reaction conditions: 5/zl of fluid +  20/Ig of complement protein (in 50/~1), with phos- 
phate-buffered saline  (pH  7.4)  added  to  give  a  volume  of  200 /zl.  The  mixture was  then 
incubated at 37°C  for 10 rain. P.  A.  WARD,  S.  COHEN,  AND  T.  D.  FLANAGAN  1101 
from chicken embryos infected with either NDV or MV were able to generate 
leukotactic activity in the presence of either C3 or C5, although substantially 
more activity was generated from C5. Curiously, little or not activity could be 
generated from either complement component when fluid from MV-infected 
BGM cell cultures was used. 
DISCUSSION 
Induction of the inflammatory  response in tissues infected by viruses may  be 
associated with the elaboration of chemotactic  factors that cause the accumu- 
ation of various kinds of inflammatory  cells.  These  tissue-dependent  chemo- 
tactic factors fall into two distinct categories: those that are fully formed and 
those that require interaction with serum factors. In the present studies, viruses 
appear to cause the elaboration of "complete" leukotactic factors, that is,  no 
additional interaction between virus and/or virus product and serum or com- 
plement is required. This is somewhat similar to the case of bacteria which, in 
the presence of replication, release leukotactic factors of high (> 20,000)  and 
low (< 10,000) molecular weights (14, 19). These factors are fully active and in- 
dependent of serum factors, although it should be pointed out that same bac- 
teria also  release generators  (C3  and  C5  dependent)  of leukotactic  activity. 
Within experimental limits, the data presented in this paper (Table II) suggest 
that the leukotactic factor(s) elaborated by virus infection of chicken embryo 
or BGM cell cultures are not products that can be detected in uninfected cells. 
Whether the factors described in the present study are synthesized or are de 
novo  produced from precursor substances in  cells cannot be determined from 
the data presented. 
As shown by the density gradient studies, Table I,  Fig.  1,  the leukotactic 
factors obtained from either infected chicken embryos or BGlVI cell cultures do 
not appear to be associated with intact virus particles. As seen in (Fig. 2) ultra- 
centrifugally simiar leukotactic factors are released into allantoic fluid during 
infection with two different viruses. This suggests that production of the leu- 
kotactic factors is a function of properties of the infected cell rather than the 
particular  infecting virus.  There are,  of  course,  other possible  explanations. 
The more limited pattern of leukotactic activity in the infected BGM cultures 
may reflect a greater homogeneity of cell population in these cultures as com- 
pared with the chicken embryo. An additional possibility must be considered: 
the presence in the embryo of C5 could furnish the substrate for a CS-cleaving 
enzyme. 
It is known that leukotactic factors may be produced by tissue damage. This 
depends on the release of a  proteolytic enzyme. Hurley (20)  found that  dis- 
rupted normal tissue incubated with serum resulted in generation of neutrophil 
leukotactic activity. Hill and Ward (10) showed that this was due to the cleav- 
age of C3 by a neutral protease, naturally residing in many tissues and released 
under the conditions of anoxia (21). Neutrophilic granulocytes contain within 1102  VIRAL  LEUKOTACTIC  FACTORS 
their lysosomal enzymes a neutral protease capable of cleaving a leukotactically 
active peptide from C5  (11), This enzyme can be released under the influence 
of phagocytic events in the neutrophil  (11). A similar C5-cleaving enzyme has 
been found in the kidney cells and its release has been documented by Brier 
et ah (12)  in the case of infection with the herpes simplex virus, as pointed out 
above. The present studies extend these findings and indicate that C3- and C5- 
dependent leukotactic factor-generating enzymes can be released from chicken 
embryos or BGM cell cultures, as a consequence of infection with two different 
viruses. The predominant factor released  that has  ability  to generate  leuko- 
tactic activity is the C5-dependent generator of leukotactic activity. Of course, 
the release of these leukotactic factor generators may  simply be  secondary to 
virus-induced cell injury. This is in contrast to the leukotactic factors, defined 
in the present study, that do not require an exogenous complement source, and 
which cannot be obtained from lysates of uninfected cells. 
The generation of leukotactic activity for both neutrophils and macrophages 
in the course of virus infection may be analogous to the production of interferon 
and, if it occurs in vivo, may similarly serve a protective role. In this regard, al- 
though  the relationship between  elaboration of interferon activity and leuko- 
tactic activity has not been determined in these experiments, it is likely that the 
two activities are not properties of the same molecule. Most  of our activity was 
associated  with  material  whose  behavior  in  the  ultracentrifuge  suggests  a 
molecular weight of approximately 150,000,  which is higher than any reported 
value for interferon.  Also  interferon  activity  is  species  specific,  whereas  the 
factors described here were obtained from chicken or  monkey cells and were 
active against inflammatory cells of rabbit origin. 
SU313IARY 
Infection of chick embryos wih either Newcastle disease virus or mumps vi- 
rus and infection of BGM cell cultures with mumps virus result in the elabora- 
tion  of chemotactic  activity /or neutrophils  and  macrophages. These  factors 
cannot be found in lysates of uninfected cells.  They do not appear to be asso- 
ciated with the viral particles per se, but rather are present in virus-free super- 
nares from infected fluids. Ultracentrifugal studies of the neutrophil chemotactic 
activity in allantoic fluid of embryos infected with the two different viruses in- 
dicate a similar biphasic distribution of activity, while fluid from the mamma- 
lian cell cultures shows a single zone of leukotactic activity, further suggesting 
that the infected cell, rather than the virus, is responsible for the leukotactic 
activity. 
Virus-infected cells also release a substance(s) which is itself not leukotactic 
but which can interact with human C3 or C5 to generate such activity. This leu- 
kotactic  factowgenerating  substance  is  similar  to  that  reported  in  another 
virus-infected cell system. 
It is postulated that the leukotactic factors elaborated as a result of virus in- 
fection of cells may play a protective role in vivo. P.  A.  WARD~ S.  COHEN, AND  T.  D.  :FLANAGAN  1103 
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